These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26575077)

  • 1. JAMA Patient Page. Prostate Cancer Screening.
    Razmaria AA
    JAMA; 2015 Nov; 314(19):2096. PubMed ID: 26575077
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informed decision making about prostate cancer screening.
    Vickers AJ
    Ann Intern Med; 2015 Mar; 162(6):457-8. PubMed ID: 25775325
    [No Abstract]   [Full Text] [Related]  

  • 4. Informed decision making about prostate cancer screening.
    O'Callaghan ME; Kichenadasse G; Vatandoust S; Moretti K
    Ann Intern Med; 2015 Mar; 162(6):457. PubMed ID: 25775324
    [No Abstract]   [Full Text] [Related]  

  • 5. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
    Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
    CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice. Screening for prostate cancer.
    Hoffman RM
    N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
    [No Abstract]   [Full Text] [Related]  

  • 7. A simple schema for informed decision making about prostate cancer screening.
    Vickers AJ; Edwards K; Cooperberg MR; Mushlin AI
    Ann Intern Med; 2014 Sep; 161(6):441-2. PubMed ID: 25222389
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of knowledge regarding prostate-specific antigen screening: is ignorance bliss?
    Hahn DL
    J Fam Pract; 1999 Sep; 48(9):679-81. PubMed ID: 10498073
    [No Abstract]   [Full Text] [Related]  

  • 9. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
    Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
    Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT.
    Chan EC; McFall SL; Byrd TL; Mullen PD; Volk RJ; Ureda J; Calderon-Mora J; Morales P; Valdes A; Kay Bartholomew L
    Patient Educ Couns; 2011 Aug; 84(2):e44-51. PubMed ID: 21237611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial.
    Taneja SS
    J Urol; 2014 May; 191(5):1286-7. PubMed ID: 24745485
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy.
    Nazim SM; Raza SJ; Ather MH
    J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969
    [No Abstract]   [Full Text] [Related]  

  • 14. Numbers needed to decide.
    Woloshin S; Schwartz LM
    J Natl Cancer Inst; 2009 Sep; 101(17):1163-5. PubMed ID: 19671771
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
    Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
    J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 17. Guideline of guidelines: prostate cancer screening.
    Loeb S
    BJU Int; 2014 Sep; 114(3):323-5. PubMed ID: 24981126
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation momentum: the relentless pursuit to resolve uncertainty.
    Sah S; Elias P; Ariely D
    JAMA Intern Med; 2013 May; 173(10):932-3. PubMed ID: 23588200
    [No Abstract]   [Full Text] [Related]  

  • 20. The roulette wheel: an aid to informed decision making.
    Hoffman JR; Wilkes MS; Day FC; Bell DS; Higa JK
    PLoS Med; 2006 Jun; 3(6):e137. PubMed ID: 16752950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.